Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2011 1
2012 1
2014 1
2015 1
2016 1
2017 1
2018 1
2019 1
2020 4
2021 10
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
A COVID-19-association-dependent categorization of death causes in 100 autopsy cases.
Danics K, Pesti A, Törő K, Kiss-Dala N, Szlávik J, Lakatos B, Radnai A, Balázs T, Bacskai M, Dobi D, Várkonyi T, Glasz T, Lotz G, Kiss A, Schaff Z, Vályi-Nagy I. Danics K, et al. Among authors: szlavik j. Geroscience. 2021 Oct;43(5):2265-2287. doi: 10.1007/s11357-021-00451-w. Epub 2021 Sep 11. Geroscience. 2021. PMID: 34510338 Free PMC article.
Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection.
Sinkovits G, Mező B, Réti M, Müller V, Iványi Z, Gál J, Gopcsa L, Reményi P, Szathmáry B, Lakatos B, Szlávik J, Bobek I, Prohászka ZZ, Förhécz Z, Csuka D, Hurler L, Kajdácsi E, Cervenak L, Kiszel P, Masszi T, Vályi-Nagy I, Prohászka Z. Sinkovits G, et al. Among authors: szlavik j. Front Immunol. 2021 Mar 25;12:663187. doi: 10.3389/fimmu.2021.663187. eCollection 2021. Front Immunol. 2021. PMID: 33841446 Free PMC article. Clinical Trial.
Simultaneous effective treatment of critical COVID-19 disease and newly diagnosed high-risk multiple myeloma with thalidomide, methylprednisolone, tocilizumab and baricitinib: is it clinically feasible?
Szabo BG, Lorinczi C, Szanka J, Lakatos B, Sinko J, Szlavik J, Mikala G. Szabo BG, et al. Among authors: szlavik j. Minerva Med. 2021 Dec 3. doi: 10.23736/S0026-4806.20.07050-0. Online ahead of print. Minerva Med. 2021. PMID: 34856779 Free article. No abstract available.
Laboratory parameters predicting mortality of adult in-patients with COVID-19 associated cytokine release syndrome treated with high-dose tocilizumab.
Lakatos B, Szabo BG, Bobek I, Gopcsa L, Beko G, Kiss-Dala N, Petrik B, Gaspar Z, Farkas BF, Sinko J, Remenyi P, Szlavik J, Valyi-Nagy I. Lakatos B, et al. Among authors: szlavik j. Acta Microbiol Immunol Hung. 2021 Aug 6. doi: 10.1556/030.2021.01526. Online ahead of print. Acta Microbiol Immunol Hung. 2021. PMID: 34370690
Common points of therapeutic intervention in COVID-19 and in allogeneic hematopoietic stem cell transplantation associated severe cytokine release syndrome.
Gopcsa L, Bobek I, Bekő G, Lakatos B, Molnár E, Réti M, Reményi P, Sinkó J, Szlávik J, Tatai G, Vályi-Nagy I. Gopcsa L, et al. Among authors: szlavik j. Acta Microbiol Immunol Hung. 2021 Nov 19. doi: 10.1556/030.2021.01620. Online ahead of print. Acta Microbiol Immunol Hung. 2021. PMID: 34797216
Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary.
Szabo BG, Lenart KS, Petrik B, Gaspar Z, Kiss-Dala N, Szlavik J, Valyi-Nagy I, Lakatos B; Saint Ladislaus COVID-19 Collaborative. Szabo BG, et al. Among authors: szlavik j. Geroscience. 2021 Oct;43(5):2205-2213. doi: 10.1007/s11357-021-00452-9. Epub 2021 Sep 3. Geroscience. 2021. PMID: 34476717 Free PMC article.
Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study.
Amele S, Peters L, Rodger A, Lundgren J, Rockstroh J, Matulionyte R, Leen C, Jabłonowska E, Østergaard L, Bhagani S, Sarcletti M, Clarke A, Falconer K, Wandeler G, Domingo P, Maltez F, Zaccarelli M, Chkhartisvili N, Szlavik J, Stephan C, Fonquernie L, Aho I, Mocroft A; EuroSIDA study group. Amele S, et al. Among authors: szlavik j. J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):248-257. doi: 10.1097/QAI.0000000000002541. J Acquir Immune Defic Syndr. 2021. PMID: 33079903 Free article.
25 results